{"id":9288,"date":"2024-05-10T16:22:16","date_gmt":"2024-05-10T08:22:16","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9288"},"modified":"2024-05-11T10:32:45","modified_gmt":"2024-05-11T02:32:45","slug":"the-board-of-directors-release-the-prohibition-on-managers-from-participation-in-competition-businesses-5","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-release-the-prohibition-on-managers-from-participation-in-competition-businesses-5\/","title":{"rendered":"The Board of Directors release the prohibition on managers from participation in competition businesses."},"content":{"rendered":"<p>&nbsp;<\/p>\n<table class=\"hasBorder\">\n<tbody>\n<tr>\n<td class=\"tblHead\">SEQ_NO<\/td>\n<td class=\"odd\">\u00a02<\/td>\n<td class=\"tblHead\">Date of announcement<\/td>\n<td class=\"odd\">2024\/05\/10<\/td>\n<td class=\"tblHead\">Time of announcement<\/td>\n<td class=\"odd\">16:05:55<\/td>\n<\/tr>\n<tr>\n<td class=\"tblHead\">Subject<\/td>\n<td class=\"odd\" colspan=\"5\">\n<pre>The Board of Directors release the prohibition on\r\nmanagers from participation in competition businesses.<\/pre>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"tblHead\">Date of events<\/td>\n<td class=\"odd\">2024\/05\/10<\/td>\n<td class=\"tblHead\">To which item it meets<\/td>\n<td class=\"odd\" colspan=\"3\">paragraph 21<\/td>\n<\/tr>\n<tr>\n<td class=\"tblHead\">Statement<\/td>\n<td class=\"odd\" colspan=\"5\">\n<pre>1.Date of the board of directors resolution:\r\n  2024\/05\/10\r\n2.Name and title of the managerial officer with\r\n  permission to engage in competitive conduct:\r\n  Chou Cheng-Hsiao,CFO.\r\n3.Items of competitive conduct in which the \r\n  officer is permitted to engage:\r\n  Acting in the business of the same or similar\r\n  nature of a company as that of the company.\r\n4.Period of permission to engage in the competitive\r\n  conduct:\r\n  For the duration of being employed as a manager \r\n  of the Company.\r\n5.Circumstances of the resolution (please describe \r\n  the results of voting in accordance with Article\r\n  32 of the Company Act):\r\n  All directors present at the meeting pass unanimously.\r\n6.If the permitted competitive conduct belongs to \r\n  the operator of a mainland China area enterprise, the\r\n  name and title of the managerial officer (if it is not\r\n  the operator of a mainland China area enterprise, \r\n  please enter \u201cN\/A\u201d below):N\/A\r\n7.Company name of the mainland China area enterprise \r\n  and the officer's position in the enterprise:N\/A\r\n8.Address of the mainland China area enterprise:N\/A\r\n9.Operations of the mainland China area enterprise:N\/A\r\n10.Impact on the company's finance and business:None\r\n11.If the managerial officer has invested in the\r\n   mainland China area enterprise, the monetary amount \r\n   of the investment and the officer's shareholding \r\n   ratio: N\/A\r\n12.Any other matters that need to be specified:None.\r\n<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; SEQ_NO \u00a02 Date of announcement 2024\/05\/10 Time of announcement 16:05:55 Subject The Board of Directors release the prohibition on managers from participation in competition businesses. Date of events 2024\/05\/10 To which item it meets paragraph 21 Statement 1.Date of the board of directors resolution: 2024\/05\/10 2.Name and title of the managerial officer with permission &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-release-the-prohibition-on-managers-from-participation-in-competition-businesses-5\/\"> <span class=\"screen-reader-text\">The Board of Directors release the prohibition on managers from participation in competition businesses.<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9288","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9288"}],"version-history":[{"count":3,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9288\/revisions"}],"predecessor-version":[{"id":9292,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9288\/revisions\/9292"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}